BRNS Annual Operating Expenses
$81.25 M
+$33.75 M+71.05%
31 December 2023
Summary:
As of January 23, 2025, BRNS annual total operating expenses is $81.25 million, with the most recent change of +$33.75 million (+71.05%) on December 31, 2023. During the last 3 years, it has risen by +$59.67 million (+276.39%). BRNS annual operating expenses is now at all-time high.BRNS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Quarterly Operating Expenses
$23.74 M
+$6.15 M+34.95%
30 September 2024
Summary:
As of January 23, 2025, BRNS quarterly total operating expenses is $23.74 million, with the most recent change of +$6.15 million (+34.95%) on September 30, 2024. Over the past year, it has increased by +$4.29 million (+22.07%). BRNS quarterly operating expenses is now -24.54% below its all-time high of $31.46 million, reached on December 31, 2022.BRNS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.0% | +22.1% |
| 3 y3 years | +276.4% | -24.5% |
| 5 y5 years | - | +48.3% |
BRNS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.8% | -24.5% | +6941.8% |
| 5 y | 5-year | at high | +276.4% | -24.5% | +6941.8% |
| alltime | all time | at high | +276.4% | -24.5% | +6941.8% |
Barinthus Biotherapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.74 M(+34.9%) |
| June 2024 | - | $17.59 M(+7.8%) |
| Mar 2024 | - | $16.32 M(-16.1%) |
| Dec 2023 | $81.25 M(+71.0%) | $19.45 M(+30.5%) |
| Sept 2023 | - | $14.90 M(-42.9%) |
| June 2023 | - | $26.11 M(+25.6%) |
| Mar 2023 | - | $20.80 M(-33.9%) |
| Dec 2022 | $47.50 M | $31.46 M(-9166.3%) |
| Sept 2022 | - | -$347.00 K(-111.6%) |
| June 2022 | - | $3.00 M(-77.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $13.32 M(-13.8%) |
| Dec 2021 | $41.49 M(+92.2%) | - |
| Dec 2021 | - | $15.46 M(+236.3%) |
| Sept 2021 | - | $4.60 M(-71.3%) |
| June 2021 | - | $16.00 M(+194.6%) |
| Mar 2021 | - | $5.43 M(-44.0%) |
| Dec 2020 | $21.59 M | $9.70 M(+216.2%) |
| Sept 2020 | - | $3.07 M(-26.4%) |
| June 2020 | - | $4.17 M(-10.5%) |
| Mar 2020 | - | $4.66 M |
FAQ
- What is Barinthus Biotherapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual operating expenses year-on-year change?
- What is Barinthus Biotherapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly operating expenses year-on-year change?
What is Barinthus Biotherapeutics annual total operating expenses?
The current annual operating expenses of BRNS is $81.25 M
What is the all time high annual operating expenses for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual total operating expenses is $81.25 M
What is Barinthus Biotherapeutics annual operating expenses year-on-year change?
Over the past year, BRNS annual total operating expenses has changed by +$33.75 M (+71.05%)
What is Barinthus Biotherapeutics quarterly total operating expenses?
The current quarterly operating expenses of BRNS is $23.74 M
What is the all time high quarterly operating expenses for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly total operating expenses is $31.46 M
What is Barinthus Biotherapeutics quarterly operating expenses year-on-year change?
Over the past year, BRNS quarterly total operating expenses has changed by +$4.29 M (+22.07%)